Siemens Case Studies Digital Twin in Pharmaceutical Manufacturing

Edit This Case Study Record

	Digital Twin in Pharmaceutical Manufacturing Siemens

Digital Twin in Pharmaceutical Manufacturing

Siemens

Technology Category	Analytics & Modeling - Digital Twin / Simulation
Applicable Industries	Pharmaceuticals
Applicable Functions	Process Manufacturing
Use Cases	Digital Twin
Challenge	GSK wanted to improve their vaccine manufacturing processes and see how they could effectively optimize the development process. Read More
About Customer	GlaxoSmithKline (GSK) is one of the world's largest research-based pharmaceutical companies that that discovers, develops, manufactures and markets human health products. It is an innovative company that produces branded products only, which it has developed itself. Read More
Customer Name	GSK Read More
Solution	GSK partnered with Siemens and Atos to create a digital twin of their factory process for creating a vaccine adjuvant, a molecule that helps spark a robust immune response. The twin allows GSK to tweak, innovate, and simulate the entire process, unlocking hidden gains and fixing problems before they happen. GSK plans to gradually implement digital twins into more and more processes, and eventually incorporate them into vaccine R&D, as well, where reduced need for real experimentation may make the process quicker, more cost effective, and sustainable. Read More Log in to view content
Contents

Technology Category

Analytics & Modeling - Digital Twin / Simulation

Applicable Industries

Pharmaceuticals

Applicable Functions

Process Manufacturing

Use Cases

Digital Twin

Challenge

GSK wanted to improve their vaccine manufacturing processes and see how they could effectively optimize the development process.

About Customer

GlaxoSmithKline (GSK) is one of the world's largest research-based pharmaceutical companies that that discovers, develops, manufactures and markets human health products. It is an innovative company that produces branded products only, which it has developed itself.

Customer Name

GSK

Solution

GSK partnered with Siemens and Atos to create a digital twin of their factory process for creating a vaccine adjuvant, a molecule that helps spark a robust immune response.

The twin allows GSK to tweak, innovate, and simulate the entire process, unlocking hidden gains and fixing problems before they happen.

GSK plans to gradually implement digital twins into more and more processes, and eventually incorporate them into vaccine R&D, as well, where reduced need for real experimentation may make the process quicker, more cost effective, and sustainable.

Impact #1	[Efficiency Improvement - Production] “This digital ‘factory’ allows us to simulate, monitor closely, anticipate failures, and optimise quality and self-learning,” GSK said. “The performance data obtained from real run is fed back into the development process and helps optimise products and processes at an early stage.”
Impact #2	[Data Management - Data Simulation] If you can understand the causes of variabilities in the manufacturing process, you have the potential to make it right the first time. Modeling inconsistencies in the manufacturing process may help minimize risk and help facilities transfer capabilities, as well.

Impact #1

[Efficiency Improvement - Production]

“This digital ‘factory’ allows us to simulate, monitor closely, anticipate failures, and optimise quality and self-learning,” GSK said. “The performance data obtained from real run is fed back into the development process and helps optimise products and processes at an early stage.”

Impact #2

[Data Management - Data Simulation]

If you can understand the causes of variabilities in the manufacturing process, you have the potential to make it right the first time. Modeling inconsistencies in the manufacturing process may help minimize risk and help facilities transfer capabilities, as well.

Download PDF Version

Overview

Digital Twin in Pharmaceutical Manufacturing

Operational Impact